GRAIL and Premier’s PINC AI Partner to Support Patient Access to Galleri Multi-Cancer Early Detection Blood Test
January 10, 2022 at 08:15 am EST
Share
GRAIL, LLC, announced a collaboration with Premier, Inc.'s PINC AI, an advanced technology and services platform that provides artificial intelligence-enabled clinical performance improvement technologies, to support patient access to Galleri, GRAILs ground breaking multi-cancer early detection blood test. Under the partnership, Premiers PINC AI will augment its AI-enabled clinical decision support technology to alert clinicians to patients who present an elevated risk of cancer and may benefit from early detection with the Galleri test. The alert will be evidence-based, integrated in the workflow and is expected to be compatible with existing electronic medical record systems. Indianapolis-based Community Health Network is expected to be the first health system to pilot candidate alerts.
Premier, Inc. is a healthcare improvement company uniting an alliance of approximately 4,350 United States hospitals and health systems and approximately 300,000 other providers and organizations. It operates through two segments: Supply Chain Services and Performance Services. The Supply Chain Services segment includes the Companyâs group purchasing organizations (GPO), supply chain co-management, purchased services, and direct sourcing activities. The Performance Services segment consists of three sub-brands, which include PINC AI, the Companyâs technology and services platform; Contigo Health, the Companyâs direct-to-employer business; and Remitra, the Companyâs digital invoicing and payables business. It delivers technology-enabled platform that offers critical supply chain services, clinical, financial, operational and value-based care software as a service (SaaS) as well as clinical and enterprise analytics licenses, consulting services, and third-party administrator services.
PREMIER, INC. 
